Source: Medicines and Medical Devices Safety Authority (NZ) Revision Year: 2017 Publisher: Distributed on behalf of Mundipharma New Zealand Limited by: Pharmaco (N.Z.) Ltd, 4 Fisher Crescent, Mt Wellington, Auckland 1060, Ph: (09) 377-3336, Toll Free [Medical Enquiries]: 0800 773 310
DHC CONTINUS 60mg tablets.
| Pharmaceutical Form |
|---|
|
Tablets: White, biconvex, capsule-shaped 12mm in length and 5mm wide, plain on one side and embossed DHC 60 on the other. |
Dihydrocodeine hydrogen tartrate 60mg.
Excipient(s) with known effect: Lactose anhydrate.
For full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Dihydrocodeine |
Dihydrocodeine is a semisynthetic narcotic analgesic with a potency between morphine and codeine. It is also a centrally-acting anti-tussive. Dihydrocodeine works on the cough centre to lessen the incidence and intensity of coughing fits. |
| List of Excipients |
|---|
|
Anhydrous lactose, hydroxyethylcellulose, cetostearyl alcohol, magnesium stearate and purified talc |
60 tablets. Bottles with polypropylene lid and polyethylene body.
Distributed on behalf of Mundipharma New Zealand Limited by: Pharmaco (N.Z.) Ltd, 4 Fisher Crescent, Mt Wellington, Auckland 1060, Ph: (09) 377-3336, Toll Free [Medical Enquiries]: 0800 773 310
26 March 1992
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
